Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
33%
Ph phase_2
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
withdrawn133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)

NCT05700695
withdrawnphase_2

Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma

NCT03908255
unknownnot_applicable

Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.

NCT05093218

Clinical Trials (3)

Showing 3 of 3 trials
NCT05700695Phase 1

Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)

Completed
NCT03908255Phase 2

Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma

Withdrawn
NCT05093218Not Applicable

Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3